224 related articles for article (PubMed ID: 29074982)
1. Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease R6/2 mice.
Soylu-Kucharz R; Sandelius Å; Sjögren M; Blennow K; Wild EJ; Zetterberg H; Björkqvist M
Sci Rep; 2017 Oct; 7(1):14114. PubMed ID: 29074982
[TBL] [Abstract][Full Text] [Related]
2. Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
Byrne LM; Rodrigues FB; Blennow K; Durr A; Leavitt BR; Roos RAC; Scahill RI; Tabrizi SJ; Zetterberg H; Langbehn D; Wild EJ
Lancet Neurol; 2017 Aug; 16(8):601-609. PubMed ID: 28601473
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.
Byrne LM; Rodrigues FB; Johnson EB; Wijeratne PA; De Vita E; Alexander DC; Palermo G; Czech C; Schobel S; Scahill RI; Heslegrave A; Zetterberg H; Wild EJ
Sci Transl Med; 2018 Sep; 10(458):. PubMed ID: 30209243
[TBL] [Abstract][Full Text] [Related]
4. Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?
Niemelä V; Landtblom AM; Blennow K; Sundblom J
PLoS One; 2017; 12(2):e0172762. PubMed ID: 28241046
[TBL] [Abstract][Full Text] [Related]
5. Translatable plasma and CSF biomarkers for use in mouse models of Huntington's disease.
Bondulich MK; Phillips J; Cañibano-Pico M; Nita IM; Byrne LM; Wild EJ; Bates GP
Brain Commun; 2024; 6(1):fcae030. PubMed ID: 38370446
[TBL] [Abstract][Full Text] [Related]
6. Plasma neurofilament light in Huntington's disease: A marker for disease onset, but not symptom progression.
Parkin GM; Corey-Bloom J; Snell C; Castleton J; Thomas EA
Parkinsonism Relat Disord; 2021 Jun; 87():32-38. PubMed ID: 33940564
[TBL] [Abstract][Full Text] [Related]
7. Cortical microstructural correlates of plasma neurofilament light chain in Huntington's disease.
Sampedro F; Pérez-Pérez J; Martínez-Horta S; Pérez-González R; Horta-Barba A; Campolongo A; Izquierdo C; Pagonabarraga J; Gómez-Ansón B; Kulisevsky J
Parkinsonism Relat Disord; 2021 Apr; 85():91-94. PubMed ID: 33770670
[TBL] [Abstract][Full Text] [Related]
8. Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.
Scahill RI; Zeun P; Osborne-Crowley K; Johnson EB; Gregory S; Parker C; Lowe J; Nair A; O'Callaghan C; Langley C; Papoutsi M; McColgan P; Estevez-Fraga C; Fayer K; Wellington H; Rodrigues FB; Byrne LM; Heselgrave A; Hyare H; Sampaio C; Zetterberg H; Zhang H; Wild EJ; Rees G; Robbins TW; Sahakian BJ; Langbehn D; Tabrizi SJ
Lancet Neurol; 2020 Jun; 19(6):502-512. PubMed ID: 32470422
[TBL] [Abstract][Full Text] [Related]
9. Mapping neurodegeneration across the Huntington's disease spectrum: a five-year longitudinal analysis of plasma neurofilament light.
Parkin GM; Thomas EA; Corey-Bloom J
EBioMedicine; 2024 Jun; 104():105173. PubMed ID: 38815362
[TBL] [Abstract][Full Text] [Related]
10. Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease.
Constantinescu R; Romer M; Oakes D; Rosengren L; Kieburtz K
Parkinsonism Relat Disord; 2009 Mar; 15(3):245-8. PubMed ID: 19056308
[TBL] [Abstract][Full Text] [Related]
11. Neurofilament light protein in blood predicts regional atrophy in Huntington disease.
Johnson EB; Byrne LM; Gregory S; Rodrigues FB; Blennow K; Durr A; Leavitt BR; Roos RA; Zetterberg H; Tabrizi SJ; Scahill RI; Wild EJ;
Neurology; 2018 Feb; 90(8):e717-e723. PubMed ID: 29367444
[TBL] [Abstract][Full Text] [Related]
12. Interaction between sex and neurofilament light chain on brain structure and clinical severity in Huntington's disease.
Sampedro F; Martinez-Horta S; Pérez-Pérez J; Perez-Gonzalez R; Horta-Barba A; Campolongo A; Aracil-Bolaños I; Gomez-Anson B; Kulisevsky J
Ann Clin Transl Neurol; 2021 Dec; 8(12):2309-2313. PubMed ID: 34761569
[TBL] [Abstract][Full Text] [Related]
13. Establishment of neurofilament light chain Simoa assay in cerebrospinal fluid and blood.
Hendricks R; Baker D; Brumm J; Davancaze T; Harp C; Herman A; Büdingen HV; Townsend M; Fischer SK
Bioanalysis; 2019 Aug; 11(15):1405-1418. PubMed ID: 31401845
[No Abstract] [Full Text] [Related]
14. Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases.
Bacioglu M; Maia LF; Preische O; Schelle J; Apel A; Kaeser SA; Schweighauser M; Eninger T; Lambert M; Pilotto A; Shimshek DR; Neumann U; Kahle PJ; Staufenbiel M; Neumann M; Maetzler W; Kuhle J; Jucker M
Neuron; 2016 Jul; 91(1):56-66. PubMed ID: 27292537
[TBL] [Abstract][Full Text] [Related]
15. Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer's disease.
Andersson E; Janelidze S; Lampinen B; Nilsson M; Leuzy A; Stomrud E; Blennow K; Zetterberg H; Hansson O
Neurobiol Aging; 2020 Nov; 95():143-153. PubMed ID: 32810755
[TBL] [Abstract][Full Text] [Related]
16. Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis.
Håkansson I; Tisell A; Cassel P; Blennow K; Zetterberg H; Lundberg P; Dahle C; Vrethem M; Ernerudh J
J Neuroinflammation; 2018 Jul; 15(1):209. PubMed ID: 30021640
[TBL] [Abstract][Full Text] [Related]
17. Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.
Novakova L; Zetterberg H; Sundström P; Axelsson M; Khademi M; Gunnarsson M; Malmeström C; Svenningsson A; Olsson T; Piehl F; Blennow K; Lycke J
Neurology; 2017 Nov; 89(22):2230-2237. PubMed ID: 29079686
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis.
Le ND; Muri L; Grandgirard D; Kuhle J; Leppert D; Leib SL
J Neuroinflammation; 2020 Oct; 17(1):293. PubMed ID: 33028339
[TBL] [Abstract][Full Text] [Related]
19. Plasma neurofilament light-chain and phosphorylated tau as biomarkers of disease severity in Huntington's disease: Korean cohort data.
Hwang YS; Oh E; Kim M; Lee CY; Kim HS; Chung SJ; Sung YH; Yoon WT; Cho JH; Lee JH; Kim HJ; Chang HJ; Jeon B; Woo KA; Ko SB; Kwon KY; Moon J; Shin C; Kim YE; Lee JY
J Neurol Sci; 2023 Sep; 452():120744. PubMed ID: 37541133
[TBL] [Abstract][Full Text] [Related]
20. Associations between prognostic index scores and plasma neurofilament light in Huntington's disease.
Parkin GM; Corey-Bloom J; Long JD; Snell C; Smith H; Thomas EA
Parkinsonism Relat Disord; 2022 Apr; 97():25-28. PubMed ID: 35276585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
